title: Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme.
abstract: OBJECTIVE
  To determine the effectiveness of a national screening programme for HIV infection in pregnant women.
  
  
  METHODS
  Observational study.
  
  
  METHODS
  All pregnant women presenting to antenatal or abortion clinics.
  
  
  METHODS
  Sweden, September 1987 to December 1991.
  
  
  METHODS
  Number and characteristics of infected women.
  
  
  RESULTS
  By the end of the study period 510,000 tests had been performed and 54 women with HIV infection identified (1.06/10,000). Of the 33 women identified in Stockholm, 14 women (4.4/10,000) had attended abortion clinics and 19 antenatal clinics (1.8/10,000; p < 0.05). Three women had been intravenous drug users, one was infected through a blood transfusion, and 50 were probably infected sexually. Of the 20 women who attended antenatal clinics early enough to allow an abortion, 12 continued with their pregnancies.
  
  
  CONCLUSIONS
  Testing of all women, not just those perceived to be at risk, probably contributed to the high uptake of HIV testing. With high uptake such screening provides valuable data on spread of HIV in the heterosexual population and presents opportunity for preventing transmission of HIV to children and partners.
authors.affiliation: Huddinge Hospital, Sweden.
authors.forename: S
authors.initials: S
authors.lastname: Lindgren
authors.forename: A B
authors.initials: AB
authors.lastname: Bohlin
authors.forename: M
authors.initials: M
authors.lastname: Forsgren
authors.forename: M
authors.initials: M
authors.lastname: Arneborn
authors.forename: C
authors.initials: C
authors.lastname: Ottenblad
authors.forename: K
authors.initials: K
authors.lastname: Lidman
authors.forename: B
authors.initials: B
authors.lastname: Anzén
authors.forename: M
authors.initials: M
authors.lastname: von Sydow
authors.forename: M
authors.initials: M
authors.lastname: Böttiger
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D015483:HIV Antibodies / Q000032:analysis*; D015658:HIV Infections / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D008403:Mass Screening / Q000458:organization & administration*; D009313:National Health Programs; D010865:Pilot Projects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology / Q000517:prevention & control; D011296:Prenatal Diagnosis; D015397:Program Evaluation; D013548:Sweden / Q000453:epidemiology
chemical_list: D015483:HIV Antibodies